Somerville Kurt F purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 15,539 shares of the company’s stock, valued at approximately $1,997,000.
Other large investors have also added to or reduced their stakes in the company. Danske Bank A S bought a new stake in Merck KGaA in the second quarter worth about $276,535,000. Great Lakes Advisors LLC bought a new position in shares of Merck KGaA during the 2nd quarter valued at approximately $183,444,000. Tocqueville Asset Management L.P. purchased a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $57,546,000. Edmond DE Rothschild Holding S.A. bought a new stake in shares of Merck KGaA in the 2nd quarter worth approximately $51,346,000. Finally, Danica Pension Livsforsikringsaktieselskab bought a new stake in shares of Merck KGaA in the 2nd quarter worth approximately $25,541,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
Merck KGaA stock opened at $167.38 on Thursday. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The business’s 50 day simple moving average is $162.50 and its 200 day simple moving average is $148.28. The company has a market cap of $21.63 billion, a price-to-earnings ratio of 25.55 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
